Xia Mao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xia Mao has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Na Lin
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
2 shared publications - Yanqiong Zhang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
2 shared publications - Funeng Jiang
Department of Geriatrics, National Clinical Key Specialty, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China
1 shared publication - Kexin Wang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
1 shared publication - Lingxiang Yu
Senior Department of Hepatology, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China
1 shared publication - Taixian Li
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
1 shared publication
Latest Publications
- 6 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 138, 112573
Tianhe Zhuifeng Gao reverses inflammatory response and attenuates bone/cartilage destruction in rheumatoid arthritis via PSMC2-RUNX2-COL1A1 axis based on transcriptional regulatory network analysis and experimental validation
- 6 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 138, 112573
Tianhe Zhuifeng Gao reverses inflammatory response and attenuates bone/cartilage destruction in rheumatoid arthritis via PSMC2-RUNX2-COL1A1 axis based on transcriptional regulatory network analysis and experimental validation
- Open Access
- 4 February 2022
- Published by Springer Nature in Molecular Cancer
- Vol. 21 (1) , 1-7
Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
- 4 February 2022
- Published by Springer Nature in Molecular Cancer
- Vol. 21 (1) , 1-7
Open AccessAberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy